‌

US Patent 9481677 Biaryl ether sulfonamides and their use as therapeutic agents

Patent 9481677 was granted and assigned to Xenon Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Xenon Pharmaceuticals

Current Assignee

Xenon Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94816770

Patent Inventor Names

Renata Marcella Oballa0

Zaihui Zhang0

Thilo Focken0

Julia Fonarev0

Navjot Chahal0

Shifeng Liu0

Date of Patent

November 1, 2016

Patent Application Number

143555490

Date Filed

October 30, 2012

Patent Primary Examiner

‌

Niloofar Rahmani

Patent abstract

This invention is directed to biaryl ether sulfonamides, or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9481677 Biaryl ether sulfonamides and their use as therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API